Stocks and InvestingStocks and Investing
Thu, September 9, 2021
Wed, September 8, 2021
Tue, September 7, 2021
Fri, September 3, 2021
Thu, September 2, 2021
Wed, September 1, 2021
Tue, August 31, 2021
Mon, August 30, 2021

Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Decreased Target to $180 on, Aug 30th, 2021


Published on 2024-10-27 17:48:11 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $225 to $180 on, Aug 30th, 2021.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $34 on, Tuesday, August 10th, 2021


These are the ratings of the 4 analyists that currently disagree with Raghuram


  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $160 on, Tuesday, August 10th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $75 on, Tuesday, August 10th, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $55 on, Tuesday, August 10th, 2021
  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $112 on, Thursday, June 10th, 2021